[September 16, 2014]

Research and Markets: Global Infections Caused By Picornaviridae Therapeutics Pipeline Review 2014 - 3 Companies & 5 Drug Profiles

Research and Markets (http://www.researchandmarkets.com/research/dh8h3l/infections_caused) has announced the addition of the "Infections Caused By Picornaviridae - Pipeline Review, H2 2014" report to their offering.

This report provides comprehensive information on the therapeutic development for Infections Caused By Picornaviridae, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of dministration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Infections Caused By Picornaviridae and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Involved in Therapeutics Development

• Immunomedics, Inc.
• AIMM Therapeutics B.V.
• Indian Immunologicals Limited

Drug Profiles

• Small Molecule to Inhibit Viral Protease for Viral Infections
• Interferon Lambda-1 Linked Fab Dimer
• Monoclonal Antibody for Parecho Virus Infections
• Small Molecules to Inhibit RNA Polymerase for Viral Infections
• picornavirus vaccine

For more information visit http://www.researchandmarkets.com/research/dh8h3l/infections_caused

[ Back To TMCnet.com's Homepage ]